Skip Navigation


NDT Advance Access originally published online on July 12, 2006
Nephrology Dialysis Transplantation 2006 21(10):2982-2983; doi:10.1093/ndt/gfl320
This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/10/2982    most recent
gfl320v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fogazzi, G. B.
Right arrow Articles by Daudon, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fogazzi, G. B.
Right arrow Articles by Daudon, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
(Section Editor: G. H. Neild)

Ciprofloxacin crystalluria

Giovanni B. Fogazzi1,, Giuseppe Garigali1, Claudia Brambilla2 and Michel Daudon3

1Research laboratory on urine of Unità Operativa di Nefrologia, Fondazione IRCCS, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, 2Unità Operativa di Nefrologia Ospedale S. Paolo, Milano, Italy and 3Service de Biochimie A, Hôpital Necker, Paris, France

Correspondence and offprint requests to: Giovanni B. Fogazzi, U.O. di Nefrologia, Fondazione IRCCS, Ospedale Maggiore Policlinico, Mangiagalli e Regina Elena, Via Commenda, 15 20122 Milano, Italy. Email: fogazzi{at}policlinico.mi.it

Keywords: ciprofloxacin crystalluria; crystalluria; crystalluria due to drugs; urinary sediment

Ciprofloxacin can cause crystalluria in alkaline urine (especially at pH > 7.3), both in experimental animals and in healthy human volunteers after oral or intravenous administration [1–3].

In clinical practice, a crystalluria due to ciprofloxacin was recorded in two out of 63 000 patients [4], as well as in a patient who developed obstructive uropathy due to massive ciprofloxacin crystal precipitation in the distal ureters and bladder, after a 24-day treatment at a dose of 500 mg twice daily [5]. In addition, a new case with acute renal failure and ciprofloxacin crystalluria has recently been published [6].

To our knowledge, very few images of ciprofloxacin crystals are available in the literature [2,6].

Herein, we wish to fill this void by showing several images of ciprofloxacin crystals obtained in the alkaline urine (pH = 8.5) of a healthy volunteer (one of the authors, G.B.F.), in whom a marked, transient and isolated crystalluria was obtained after the oral administration of 250 mg of ciprofloxacin and sodium bicarbonate 500 mg four times in 24 h with a normal liquid intake.

The crystals, which infrared spectroscopy performed in blind conditions by one of us (M.D.) identified as the magnesium salt of ciprofloxacin, showed a wide array of appearances.

These included: ‘needles’, ‘sheaves’, ‘stars’, ‘fans’, ‘butterflies’ and other unusual shapes, all with a lamellar structure, whose sizes ranged from 30 x 5 µm to 360 x 237 µm. Some crystals were colourless while others, especially the largest ones, showed a brownish hue. Under polarizing light, all the crystals were strongly birefringent (Figure 1).


Figure 1
View larger version (91K):
[in this window]
[in a new window]
[Download PowerPoint slide]
 
Fig. 1. Ciprofloxacin ‘needles’ (A), ‘sheaves’ (B), ‘stars’ (C) and bizarre shape (D). A, C and D: phase contrast microscopy; B: bright field microscopy. Insets: polarising light. Original magnification 4400x.

 
The crystals observed differed greatly from the crystals commonly found in the urine such as uric acid, mono- or bi-hydrated calcium oxalate, calcium phosphate or triple phosphate. They also differed from pathological crystals such as cholesterol, cystine, tyrosine, leucine or 2,8 di-hydroxyadenine.

This fact confirms the view that a drug must be considered whenever an unusual and pleomorphic crystalluria is found [7].

To prevent crystalluria, patients receiving high-dose ciprofloxacin should be well hydrated and alkalinity of the urine should be avoided [8].

Conflict of interest statement. None declared.

References

  1. Schlüter G. (1987) Ciprofloxacin: review of potential toxicologic effects. Am J Med 82 [Suppl 4A]:91–93.
  2. Thorsteinsson SB, Bergan T, Oddsdottir S, et al. (1986) Crystalluria and ciprofloxacin, influence of urinary pH and hydration. Chemotherapy 32:408–417.[Web of Science][Medline]
  3. Nix DE, Spivey JM, Normal A, et al. (1992) Dose-ranging pharmacokinetic study of ciprofloxacin after 200-, 300-, and 400 mg intravenous doses. Ann Pharmacother 26:8–10.[Abstract]
  4. Boll P and Tillotson G. (1995) Tolerability of fluoroquinolone antibiotics. Drug Safety 13:344–358.
  5. Chopra N, Fine PL, Price B, et al. (2000) Bilateral hydronephrosis from ciprofloxacin induced crystalluria and stone formation. J Urol 164:438.[CrossRef][Web of Science][Medline]
  6. Sedlacek M, Suriawinata AA, Schoolwert A, et al. (2006) Ciprofloxacin crystal nephropathy – a ‘new’ cause of acute renal failure [letter]. Nephrol Dial Transplant doi:10.1093/ndt/gfl160.
  7. Fogazzi GB, Cantù M, Saglimbeni L, et al. (2003) Amoxycillin, a rare but possible cause of crystalluria. Nephrol Dial Transplant 18:212–214.[Free Full Text]
  8. Christ W, Lehnert T, Ulbrich B. (1988) Specific toxicologic aspects of the quinolones. Rev Infect Dis 10:Suppl 1, S141–S146.
Received for publication: 2. 5.06
Accepted in revised form: 8. 5.06


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/10/2982    most recent
gfl320v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Fogazzi, G. B.
Right arrow Articles by Daudon, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fogazzi, G. B.
Right arrow Articles by Daudon, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?